Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

China Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib, Find details about China Dasatinib, Dasatinib Powder from Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Model NO.
D-Sung Dasatinib
Product Name
Dasatinib
Name
Dasatinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anthelmintics
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
302964-08-5
Mf
C16h13cl2n5OS
Density
1.516
Refractive Index
1.716
Melting Point
333-335
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Xi′an Shaanxi
Model NO.
D-Sung Dasatinib
Product Name
Dasatinib
Name
Dasatinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anthelmintics
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
302964-08-5
Mf
C16h13cl2n5OS
Density
1.516
Refractive Index
1.716
Melting Point
333-335
Trademark
D-Sung
Transport Package
Negotiable
Specification
99%
Origin
Xi′an Shaanxi
Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib
Product Description

Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Product Details

Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib

Product NameDasatinib
AppearanceWhite Powder
MFC16H13Cl2N5OS
CAS No.302964-08-5 

Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body. Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Application&Function

Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibDasatinib is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective.
Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitorapproved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Specification

Antineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer DasatinibAntineoplastic CAS 302964-08-5 Dasatinib 99% Purity Dasatinib Powder Anti-Cancer Dasatinib